811450-53-0

Upstream product

• 18677-48-0 3,5-dimethoxypyridine 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1179454-97-7 C₁₈H₂₂N₂O₅ 
• 1179454-98-8 C₂₄H₃₃N₃O₇ 
• 1166871-04-0 benzyl 3-methoxy-5-oxo-5,6-dihydropyridine-1(2H)-carboxylate 
• 1207516-53-7 benzyl 5-amino-3-oxo-3,6-dihydro-2H-pyridine-1-carboxylate 
• 1425504-34-2 (R)-benzyl 5-oxo-3-(1-(4-(6-(pyridin-4-yl)quinazolin-2-yl-amino)phenyl)ethylamino)-5,6-dihydropyridine-1(2H)-carboxylate 
• 1179455-20-9 C₁₈H₂₂N₂O₅ 
• 1222076-55-2 C₂₈H₃₆N₄O₇ 
• 1222076-54-1 C₂₉H₃₈N₄O₇ 
• 1222076-52-9 C₁₉H₂₄N₂O₅ 
• 1222076-63-2 C₅₁H₆₇N₉O₁₀ 
• 1222076-62-1 C₄₈H₆₄N₈O₁₁ 
• 1222076-61-0 C₄₉H₆₆N₈O₁₁ 
• 1222076-60-9 C₄₁H₅₃N₇O₈ 
• 1222076-59-6 C₃₈H₅₀N₆O₉ 

Relevant academic research and scientific papers

Discovery and optimization of a novel series of potent mutant B-Raf V600E selective kinase inhibitors

B-Raf represents an attractive target for anticancer therapy and the development of small molecule B-Raf inhibitors has delivered new therapies for metastatic melanoma patients. We have discovered a novel class of small molecules that inhibit mutant B-Raf

Asymmetric synthesis of (+)-castanospermine through enol ether metathesis-hydroboration/oxidation

An asymmetric synthesis of (+)-castanospermine is presented in which enol ether metathesis-hydroboration/oxidation is used for stereoselective installation of the trans-trans hydroxyl groups on the piperidine ring of the alkaloid.